Searchable abstracts of presentations at key conferences in endocrinology

ea0049ep165 | Endocrine tumours and neoplasia | ECE2017

Could alcohol ablation become the standard of care for benign insulinomas?

Mazarico Isabel , Subias David , Junquera Felix , Vilardell Carme , Saigi Ignasi , Cano Albert , Casamitjana Laia , Gimenez-Palop Olga , Albert Lara , Capel Ismael , Caixas Assumpta , Rigla Mercedes

Introduction: Surgical resection is currently considered the standard treatment for symptomatic insulinomas; however, its morbidity is high (>10%) and it is restricted to suitable candidates. In recent years, alternative minimally invasive therapies, such as endoscopic ultrasound (EUS)-guided ethanol ablation (EA), have emerged as new therapeutic options, especially for small lesions or poor surgical candidates. We report two cases of insulinoma ablated with EA.<p clas...

ea0081p4 | Adrenal and Cardiovascular Endocrinology | ECE2022

Patients with chronic kidney disease present HPA axis disregulation due to impaired glucocorticoid negative feedback

Boswell Laura , Blasco Miquel , Quintana Luis F. , Vega-Beyhart Arturo , Viaplana Judith , Rodriguez Gabriela , Diaz Daniela , Vilardell Carme , Mora Mireia , Halperin Irene , Amor Antonio J. , Casals Gregori , Hanzu Felicia A.

Aims: A few studies have shown disturbances in the hypothalamic-pituitary-adrenal (HPA) axis in chronic-kidney-disease (CKD), of unknown extent and clinical implications. We aimed to study the HPA axis in patients with CKD and its association with kidney impairment and metabolic disturbances.Methods: Cross-sectional controlled study. Patients with CKD stages I-II (estimated glomerular filtration rate [eGFR] through CKD-EPI equation >60), stage III (e...